Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @BiotechBeau
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @BiotechBeau
-
New restaurant in Back Bay opens with theme of oncology marketspic.twitter.com/MSZDuoEZaH
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Beau proslijedio/la je Tweet
Now GPCR PROTACs! Another gene family susceptible to UbP mediated degradation.
#pfizercolleague#proteindegradation https://lnkd.in/dgqd2s8Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Beau proslijedio/la je Tweet
Deerfield, one of the largest healthcare focused hedge funds, is betting BIG on both gene tx & the Philadelphia cluster. The venture will help with housing & relocation for experts who join, per release. They are calling it THE COLONY, a name JG Ballard would be proud of.https://twitter.com/syinvesting/status/1220439810915160066 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Beau proslijedio/la je Tweet
Sad to see such ignorance from a govt official. -
$BMRN does not make money. $1.7b in accum losses - HemA is not patent protected and has cost $700m to dev - Patients spend days wkly in treatment centers and $500k annually for ERT Gene therapy is a solution for budget not issuehttps://twitter.com/SenSanders/status/1218230595710607363 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Beau proslijedio/la je Tweet
Great POC study on this new complimentary approach to PROTAC. Heterobifunctional Molecules Induce Dephosphorylation of Kinases–A Proof of Concept Study - https://pubs.acs.org/doi/abs/10.1021/acs.jmedchem.9b01167 …
@DerekloweHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Beau proslijedio/la je Tweet
Oh man, cancers are just too damn smart... Why KRAS(G12C) inhibitors result in only partial responses w/ rather short durability?
$AMGN$MRTX$JNJ$LLY https://www.mskcc.org/blog/why-kras-inhibitors-lung-cancer-stop-working-and-what-can-be-done-about-it … "Rapid non-uniform adaptation to conformation-specific KRAS(G12C) inhibition" https://www.nature.com/articles/s41586-019-1884-x …pic.twitter.com/3ghHZMooBA
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Beau proslijedio/la je Tweet
Protein degradation space gaining more interest:
$SNY gets an ok from the FTC for a significant research collaboration with Nurix,@endpts reports this will be highlighted at#JPM20$ARVNhttps://www.ftc.gov/enforcement/premerger-notification-program/early-termination-notices/20200489 …Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Beau proslijedio/la je Tweet
This Media Post will serve as a reminder that war powers reside in the Congress under the United States Constitution. And that you should read the War Powers Act. And that you’re not a dictator.https://twitter.com/realDonaldTrump/status/1213919480574812160 …
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Beau proslijedio/la je Tweet
A few thoughts on the
@onemedical S-1 after digging through. I'm a big believer in rebuilding the care delivery stack, with an eye toward care continuity and the patient experience, but I think it's fair to say I started and finished my perusal with a mixed read on ONEM. 1/nhttps://twitter.com/chrissyfarr/status/1213244061248655360 …Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Beau proslijedio/la je Tweet
"Of all the antibiotics approved in the last 10 years, only 2 will have an annual revenue over $100 million in 2019." Rolf Wagenaar via
@Contagion_Live#IDTwitterhttps://twitter.com/ABsteward/status/1211359682121650178 …Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Beau proslijedio/la je Tweet
Excessive alcohol consumption associated with AFib. Patients with paroxysmal or persistent AFib who were in sinus rhythm and who were consuming 10 or more drinks per week were randomly assigned to either alcohol abstinence or continued drinking for 6 mos. https://nej.md/2MN8OIW
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Beau proslijedio/la je Tweet
A vaccine developed to treat tuberculosis, now also used to treat bladder cancer, was found to be associated with a 4x reduction in Alzheimer’s disease.https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0224433 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Beau proslijedio/la je Tweet
Cool paper. Could really improve ability to purify cell populations of interest in manufacturing of cell therapies. Example: Could capture CD3 T cells with aptamer, then add oligo antidote to seamlessly release. Very useful for the cell therapy field.https://www.cell.com/cell-chemical-biology/fulltext/S2451-9456(19)30400-3#%20 …
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Beau proslijedio/la je Tweet
PROTAC-Mediated Degradation of KRAS Protein for Anticancer Therapeuticshttp://dx.doi.org/10.1021/acsmedchemlett.9b00584 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Beau proslijedio/la je Tweet
Let’s play a little game. Let’s say that you’re the CSO at a cancer pharma company, and you have to choose a target to go after. Here’s a gene – high expression is associated with poor prognosis in brain cancer. Looks like a good candidate for an inhibitor right?pic.twitter.com/5J7fKOWh6c
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Beau proslijedio/la je Tweet
I bet the owner tried for years to share it, but no one ever replied to his emails...https://twitter.com/ctvedmonton/status/852979777698975745 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Beau proslijedio/la je Tweet
Would you pay $1 million for an unproven, untested anti-aging gene therapy?http://bit.ly/2EgW4pe
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Beau proslijedio/la je Tweet
Wow. Extraordinary graphic of proportion of drug revenues by disease area over time. Main story is about Cancer, but note early DAA era (Infection) and shift to INSTI-Rx (HIV) -- big advances with big prices. h/t
@manfordou https://www.bloomberg.com/news/articles/2019-12-12/miracle-cancer-drugs-are-making-big-pharma-billions-others-are-getting-left-behind …pic.twitter.com/0pdx7cInNv
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Beau proslijedio/la je Tweet
Oncology companies continued to attract the lion’s share of IPO dollars in 2019, with more than $2.5 billion raised https://go.nature.com/2PjcGDa - find out more about trends in 2019 IPOs in this analysis by
@CT_Morrisonpic.twitter.com/ftMylqS611
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Beau proslijedio/la je Tweet
Many recent papers about
#PROTACs, but this may be the most noteworthy one: Increasing tolerability for Bcl-XL targeting with a VHL-based degrader by boosting anti-tumor efficacy while sparing platelets (due to low expression of VHL) (1/2)@NatureMedicine https://www.nature.com/articles/s41591-019-0668-z …pic.twitter.com/2l78btysFw
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.